Amnion in the treatment of pediatric partial-thickness facial burns.

Amnion in the treatment of pediatric partial-thickness facial burns. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Amnion in the treatment of pediatric partial-thickness facial burns. Abstract Text:

BACKGROUND: Wound coverage for second-degree burns remains a clinical challenge. Human amniotic membranes have been used for many years in the treatment of burns; however, no large prospective clinical trials have been published. In this article, we present a novel and standardized procurement and processing method for amnion and investigate, whether the use of this biological dressing is safe and may represent a new therapeutic option for children with partial-thickness facial burns compared to standard topical treatment. METHODS: Patients with partial-thickness burns of the face, neck and head admitted between 2003 and 2005 were included in this study. They were divided into two groups to receive either amnion (n=53) or topical antimicrobials (n=49). Demographics (age, gender, ethnicity, TBSA, burn areas), length of hospital stay (LOS), rate of infections (RI), time to total healing, and frequency of dressing changes were compared between the two groups. The long-term outcome was assessed in nine patients in the amnion group and eight patients in the topical group, who returned for up to 12-month follow-up visits. RESULTS: Patients in the amnion group had significantly less dressing changes then in the control group (p<0.05). Time to healing, length of stay and the development of hypertrophic scarring was not different between the groups. Use of amnion was not associated with an increased risk of local infection. CONCLUSION: This study indicates that amnion is safe and has advantages as wound coverage for second-degree facial burns compared to the standard topical ointments. Further studies with the use of amniotic membranes on the trunk and the extremities, as well as for coverage of grafted third-degree burns, have yet to be performed.

Amnion in the treatment of pediatric partial-thickness facial burns. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Amnion in the treatment of pediatric partial-thickness facial burns. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Burns : journal of the International Society for B

VOLUME: 34

Page Numbers: 393-9

Journal Abbreviation:

ISSN: 0305-4179

DAY: 24

MONTH: 10

YEAR: 2007

Amnion in the treatment of pediatric partial-thickness facial burns. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8913178

Amnion in the treatment of pediatric partial-thickness facial burns. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Amnion in the treatment of pediatric partial-thickness facial burns. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Amnion in the treatment of pediatric partial-thickness facial burns.

AFFILIATION: Shriners Hospital for Children and University of Texas Medical Branch, 815 Market Street, Galveston, TX 77550, USA.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Burns

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Amnion in the treatment of pediatric partial-thickness facial burns Related Publications

• A pulsed EPR study of surfactant layer structure in composites of a synthetic layered silicate with polystyrene and polycaprolactone.
• Amnion in the treatment of pediatric partial-thickness facial burns.
• Are serum cytokines early predictors for the outcome of burn patients with inhalation injuries who do not survive?
• Erythropoietin and erythropoietin receptor expression in normal and disturbed pregnancy.
• Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina.
• Gene therapy in wound healing: present status and future directions.
• Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy.
• High-resolution structure of a Na+/H+ antiporter dimer obtained by pulsed electron paramagnetic resonance distance measurements.
• Human umbilical vascular endothelial cells express estrogen receptor beta (ERbeta) and progesterone receptor A (PR-A), but not ERalpha and PR-B.
• Inhalation injury in severely burned children does not augment the systemic inflammatory response.
• Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages.
• Insulin attenuates the cytokine response in a burn wound infection model.
• Leptin and peroxisome proliferator-activated receptors: impact on normal and disturbed first trimester human pregnancy.
• Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial.
• Peroxisome proliferator-activated receptors: new players in the field of reproduction.
• Photo-CIDNP MAS NMR beyond the T(1) limit by fast cycles of polarization extinction and polarization generation.
• Relaxation-based distance measurements between a nitroxide and a lanthanide spin label.
• Second hit post burn increased proximal gut mucosa epithelial cells damage.
• Serum cytokine differences in severely burned children with and without sepsis.
• Stabilization of microvascular pedicles in intricate locations using fibrin glue.
• The factor age and the recovery of severely burned children.
• Urinary cortisol and catecholamine excretion after burn injury in children.
• [Hemodynamics and ergometric performance modified by low dosage oral contraceptives]
• [Investigations on regulation of CRH, ACTH and cortisol in trophoblast cells in vitro]
• [Problems in the discontinuation of sterility treatment]